Fig. 5: Intestinal microbiota composition resultant from treatment with probiotic strains (ARO112, EcN) or lack thereof (Ctrl). | Nature Communications

Fig. 5: Intestinal microbiota composition resultant from treatment with probiotic strains (ARO112, EcN) or lack thereof (Ctrl).

From: Klebsiella ARO112 promotes microbiota recovery, pathobiont clearance and prevents inflammation in IBD mice

Fig. 5: Intestinal microbiota composition resultant from treatment with probiotic strains (ARO112, EcN) or lack thereof (Ctrl).

a Richness and b diversity of gut microbiota in fecal samples collected before (pre-AB, day -4), or after (post-AB, day 0) antibiotic treatment and 5 and 20 days after AIEC infections of mice treated with ARO112, EcN or PBS (Ctrl). In (a and b), lines represent median values for each treatment over time. c, Changes in the relative abundances of most prevalent taxa at day 20 after AIEC infection in comparison with the levels before antibiotics (day -4). In (a–c), data were analyzed using Two-way ANOVA with Dunnett’s correction for multiple comparisons (*p < 0.1; **p < 0.01; ***p < 0.001; ****p < 0.0001). Fecal microbiota composition analyses were performed in a total of 14 (Ctrl), 10 ( + ARO112), and 4 (day 5) or 10 (days 0,-4, 0, 20) ( + EcN) samples, from 2-3 independent experiments.

Back to article page